The study aimed to assess the safety and effectiveness of ultrasound ablation for treating uterine fibroids, involving 99 patients and 117 fibroids in a clinical trial at Chongqing Medical University.
After treatment, MRI evaluations showed an average 76% ablation area and significant reductions in fibroid volume, with 84.6% of patients achieving over 50% volume reduction at 6 months, and 92% experienced symptom improvement.
Most patients could resume normal activities within 2 hours post-treatment, and while some minor complications occurred (35%), there were no serious adverse reactions reported in the study.